| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
|
Biol Blood Marrow Transplant
|
2006
|
4.09
|
|
2
|
Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus.
|
Genome Res
|
2009
|
3.81
|
|
3
|
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
|
Arthritis Rheum
|
2013
|
3.55
|
|
4
|
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
|
Arthritis Rheum
|
2004
|
2.31
|
|
5
|
Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.
|
Rheumatology (Oxford)
|
2003
|
2.18
|
|
6
|
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
|
Lancet
|
2008
|
2.16
|
|
7
|
Age-related somatic structural changes in the nuclear genome of human blood cells.
|
Am J Hum Genet
|
2012
|
2.15
|
|
8
|
A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
|
Arthritis Rheum
|
2006
|
1.93
|
|
9
|
International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies.
|
Arthritis Rheum
|
2005
|
1.75
|
|
10
|
Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis.
|
Arthritis Rheum
|
2008
|
1.60
|
|
11
|
HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
|
Arthritis Rheum
|
2003
|
1.46
|
|
12
|
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
|
Medicine (Baltimore)
|
2006
|
1.39
|
|
13
|
Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference.
|
Arthritis Care Res (Hoboken)
|
2010
|
1.32
|
|
14
|
Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.
|
Best Pract Res Clin Rheumatol
|
2009
|
1.27
|
|
15
|
Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians.
|
Arthritis Rheum
|
2006
|
1.24
|
|
16
|
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity.
|
Medicine (Baltimore)
|
2008
|
1.22
|
|
17
|
The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
|
Medicine (Baltimore)
|
2013
|
1.19
|
|
18
|
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians.
|
Medicine (Baltimore)
|
2005
|
1.18
|
|
19
|
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.
|
Ann Rheum Dis
|
2012
|
1.15
|
|
20
|
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.
|
Arthritis Rheum
|
2013
|
1.12
|
|
21
|
Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.
|
Arthritis Rheum
|
2008
|
1.09
|
|
22
|
The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis.
|
Arthritis Care Res (Hoboken)
|
2010
|
1.05
|
|
23
|
Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM).
|
Phys Occup Ther Pediatr
|
2006
|
1.04
|
|
24
|
Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.
|
Arthritis Rheum
|
2002
|
1.01
|
|
25
|
HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies.
|
Arthritis Rheum
|
2006
|
1.00
|
|
26
|
Diagnostic criteria for polymyositis and dermatomyositis.
|
Lancet
|
2003
|
0.97
|
|
27
|
Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
|
Arthritis Rheumatol
|
2014
|
0.97
|
|
28
|
Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.
|
Dermatol Online J
|
2009
|
0.96
|
|
29
|
Walking ability and its relationship to lower-extremity muscle strength in children with idiopathic inflammatory myopathies.
|
Arch Phys Med Rehabil
|
2004
|
0.96
|
|
30
|
Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies.
|
Dermatol Online J
|
2009
|
0.95
|
|
31
|
Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies.
|
Arthritis Rheum
|
2008
|
0.94
|
|
32
|
Endothelial cell activation and neovascularization are prominent in dermatomyositis.
|
J Autoimmune Dis
|
2006
|
0.93
|
|
33
|
Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats.
|
Arthritis Rheum
|
2008
|
0.93
|
|
34
|
Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases.
|
Arthritis Res Ther
|
2011
|
0.92
|
|
35
|
Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures.
|
Arthritis Rheum
|
2007
|
0.91
|
|
36
|
Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy.
|
Arthritis Rheum
|
2007
|
0.91
|
|
37
|
Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood.
|
Ann Rheum Dis
|
2012
|
0.90
|
|
38
|
Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies.
|
Arthritis Res Ther
|
2009
|
0.90
|
|
39
|
The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.
|
Curr Rheumatol Rep
|
2014
|
0.89
|
|
40
|
Parvovirus B19 and onset of juvenile dermatomyositis.
|
JAMA
|
2005
|
0.89
|
|
41
|
Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale.
|
Arthritis Rheum
|
2004
|
0.86
|
|
42
|
Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.
|
Arthritis Rheum
|
2013
|
0.85
|
|
43
|
Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.
|
Arthritis Care Res (Hoboken)
|
2014
|
0.82
|
|
44
|
Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups.
|
Open Rheumatol J
|
2012
|
0.82
|
|
45
|
Metabolic abnormalities and cardiovascular risk factors in children with myositis.
|
J Pediatr
|
2009
|
0.81
|
|
46
|
Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.
|
J Pediatr
|
2012
|
0.81
|
|
47
|
Parents' perception of self-advocacy of children with myositis: an anonymous online survey.
|
Pediatr Rheumatol Online J
|
2011
|
0.80
|
|
48
|
Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis.
|
BMC Musculoskelet Disord
|
2014
|
0.80
|
|
49
|
Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases.
|
Arthritis Res Ther
|
2011
|
0.79
|
|
50
|
Decreased aerobic capacity in children with juvenile dermatomyositis.
|
Arthritis Rheum
|
2002
|
0.79
|
|
51
|
Fitness as a determinant of the oxygen uptake/work rate slope in healthy children and children with inflammatory myopathy.
|
Can J Appl Physiol
|
2003
|
0.79
|
|
52
|
Confusion concerning multiple versions of the childhood myositis assessment scale.
|
Arthritis Care Res (Hoboken)
|
2014
|
0.77
|
|
53
|
Clinical research networks: a step towards evidence-based practice in pediatric rheumatology.
|
Nat Clin Pract Rheumatol
|
2007
|
0.77
|
|
54
|
Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?
|
Arthritis Rheum
|
2010
|
0.77
|
|
55
|
Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy.
|
Arthritis Care Res (Hoboken)
|
2013
|
0.76
|
|
56
|
Applicability of the paediatric rheumatology international trials organisation disease activity core set for juvenile dermatomyositis: comment on the article by Ruperto et al.
|
Arthritis Rheum
|
2008
|
0.75
|
|
57
|
On Determining the Effects of Therapy on Disease Damage in Non- randomized Studies with Multiple Treatments: A study of Juvenile Myositis.
|
Commun Stat Theory Methods
|
2009
|
0.75
|
|
58
|
Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.
|
J Rheumatol
|
2015
|
0.75
|
|
59
|
Post-zygotic and inter-individual structural genetic variation in a presumptive enhancer element of the locus between the IL10Rβ and IFNAR1 genes.
|
PLoS One
|
2013
|
0.75
|
|
60
|
Developing international consensus on measures of improvement for patients with myositis.
|
Stat Methods Med Res
|
2007
|
0.75
|